pipette
ESEspañol

Determinants of mpox vaccine acceptance among peri-urban residents in Sekondi-Takoradi, Western Region of Ghana: A community-based cross-sectional study

G. Amugi, E. M. Baah, H. Yankey, I. Kwarkye, P. Mensah, K. Jean Claude, D. Jubin, S. Kaba Akoriyea, F. A. Bekoe, D. Laryea, A. Abdul-Tawab, J. Arthur, S. Kutsoati, J. Oliver-Commey, N. T. Mohammed

PreprintReal-world use

In the authors' words

Mpox re-emerged as a global public health concern in 2022, and the Western Region of Ghana became the epicentre of the countrys largest recorded outbreak in 2025. Ahead of a sub-national vaccination campaign launched in October 2025, no study had examined the determinants of mpox vaccine acceptance among peri-urban residents of the region using a theoretically grounded framework. This study determined the sociodemographic and Health Belief Model-based determinants of mpox vaccine acceptance among peri-urban residents of the Sekondi-Takoradi Metropolis, Western Region, Ghana. A community-based cross-sectional study was conducted among 580 adults in six purposively selected peri-urban areas and their surrounding communities between July and August 2025, before the vaccination campaign began. Vaccine acceptance was measured as a three-category outcome (accept, hesitant, refuse) and analysed using chi square tests and multinomial logistic regression adjusted for sociodemographic characteristics, Health Belief Model constructs, and peri-urban area. Overall, 75.7% of respondents were willing to accept the vaccine, 12.9% were hesitant and 11.4% would refuse. Perceived vaccine safety was the strongest determinant: respondents who considered the vaccine very safe had markedly lower adjusted odds of hesitancy (adjusted odds ratio 0.02, 95% confidence interval 0.00-0.12) and refusal (0.03, 0.01-0.13) than those who considered it unsafe. Uncertainty about vaccine effectiveness was associated with hesitancy (9.83, 1.95-49.50), and belief in its effectiveness with lower odds of refusal (0.22, 0.06-0.86). Higher educational attainment was associated with lower odds of hesitancy, being a student or employed with lower odds of refusal, and acceptance differed be 1 tween peri-urban areas (55.1% to 95.6%). Knowledge of mpox transmission was associated with acceptance in bivariate analysis (p < 0.001) but not after adjustment. Risk communication that addresses vaccine safety and effectiveness, rather than generic disease-awareness messaging alone, is likely to be most effec tive in improving mpox vaccine acceptance in this population, with unemployed and less-educated residents warranting targeting. As a pre-campaign baseline collected during an active outbreak, these findings can inform the vaccination response in the Western Region and preparedness in comparable peri-urban West African settings.

Main resultThe abstract does not state a limitation.

Appeared: Friday, November 13. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.10.26367771